Influence of CYP2D6, CYP2C19, and CYP2C9 Pharmacogenetics and Clinical Factors on Dose-Normalized Venlafaxine/O-Desmethylvenlafaxine Metabolic Ratio in Spanish Patients

Literals

bibo:eissn
- 1424-8247
dcterms:creator
- Thomas L.
dcterms:contributor
- Thomas L.; de la Cruz C.G.; Mata-Martin C.; Gonzalez-Rodriguez I.; Gonzalez-Martinez I.; Penas-Lledo E.M.; LLerena A.
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105031442906&origin=inward
ou:eid
- 2-s2.0-105031442906
bibo:doi
- 10.3390/ph19020209
fabio:hasPublicationYear
- 2026
vivo:identifier
- 2026-7749
dcterms:publisher
- Pharmaceuticals
ou:tipoPublicacion
- Article
dcterms:title
- Influence of CYP2D6, CYP2C19, and CYP2C9 Pharmacogenetics and Clinical Factors on Dose-Normalized Venlafaxine/O-Desmethylvenlafaxine Metabolic Ratio in Spanish Patients
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105031442906&origin=inward
ou:vecesCitado
- 0
bibo:volume
- 19